Clinical Trial: A Study to Investigate the Safety and Immunogenicity of mRNA-1469 in African Participants 1 to 65 Years of Age

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919197) titled 'A Study to Investigate the Safety and Immunogenicity of mRNA-1469 in African Participants 1 to 65 Years of Age' on Oct. 30.

Brief Summary: The main objective of this trial is to evaluate the safety of mRNA-1469

Study Start Date: Nov. 02

Study Type: INTERVENTIONAL

Condition: Ebola-Bundibugyo Virus Disease (Ebola-BDBV)

Intervention: BIOLOGICAL: mRNA-1469

Sterile liquid for injection

BIOLOGICAL: Placebo

Sterile liquid for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ModernaTX, Inc.

Disclaimer: Curated by HT Syndication....